Renee Jeanne Mendell-Harary

Title: Innovations of Renee Jeanne Mendell-Harary

Introduction

Renee Jeanne Mendell-Harary is a notable inventor based in Skillman, NJ (US). She has made significant contributions to the field of biomedical research, particularly in the identification and treatment of tumors and other diseases. With a total of two patents to her name, her work has the potential to impact patient care and treatment strategies.

Latest Patents

Mendell-Harary's latest patents include innovative methods for identifying and treating human subjects harboring tumors. One patent focuses on protein biomarkers, detailing methods to assess HRG gene expression at a protein level. This invention allows for the administration of anti-HER3 antibodies to patients with high HRG expression and withholding treatment from those with low expression. Another patent centers on nucleic acid biomarkers, which involves assessing HRG gene expression at the mRNA level, similarly guiding treatment decisions based on the expression levels.

Career Highlights

Throughout her career, Mendell-Harary has worked with prominent companies in the pharmaceutical industry, including Daiichi Sankyo Company, Limited and Amgen Inc. Her experience in these organizations has contributed to her expertise in developing innovative solutions for complex medical challenges.

Collaborations

Mendell-Harary has collaborated with esteemed colleagues such as Matthias Schneider and Sabine Blum. These partnerships have likely enhanced her research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Renee Jeanne Mendell-Harary's contributions to the field of biomedical research through her patents and collaborations highlight her role as a significant inventor. Her work continues to pave the way for advancements in the identification and treatment of diseases, showcasing the importance of innovation in healthcare.